The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combinat
- This topic has 0 replies, 1 voice, and was last updated 7 years, 2 months ago by
.
Viewing 1 post (of 1 total)
-
Posts
-
The oral VEGF receptor tyrosine kinase inhibitor pazopanib in combination with the MEK inhibitor trametinib in advanced cholangiocarcinoma.
https://www.ncbi.nlm.nih.gov/pubmed/28441383
Viewing 1 post (of 1 total)
- The forum ‘New Developments’ is closed to new topics and replies.